Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 42.67 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 40.35 | Oscillator | Neutral |
| Williams %R (14) | -47.30 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.34 (Hist 0.04) | Oscillator | Buy |
| Average Directional Index (14) | 32.52 (+DI 14.7 / -DI 35.0) | Trend | Strong Sell |
| EMA 20 | 10.17 | MA | Sell |
| SMA 20 | 9.98 | MA | Sell |
| EMA 50 | 10.82 | MA | Strong Sell |
| SMA 50 | 11.20 | MA | Strong Sell |
| SMA 200 | 14.08 | MA | Strong Sell |
Current price $9.91
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Jul 16, 25 | Stifel | maintain | Hold | Hold |
| May 13, 25 | Citigroup | maintain | Neutral | Neutral |
| Apr 15, 25 | Stifel | maintain | Hold | Hold |
| Mar 12, 25 | Citigroup | upgrade | Sell | Neutral |
| Feb 20, 25 | Citigroup | maintain | Sell | Sell |
| Oct 31, 24 | Citigroup | maintain | Sell | Sell |
| May 1, 23 | Piper Sandler | maintain | Neutral | Neutral |
| Apr 28, 23 | Stifel | maintain | Hold | Hold |
| Apr 18, 23 | B of A Securities | downgrade | Neutral | Underperform |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | CLB | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 17.7x | 34.4x · sector 14.8x | Elevated |
| Forward P/E (FY26E) | 20.8x | EPS est. 0.48 | Elevated |
| Price / Book | 1.7x | 4.3x | Discount |
| Price / Sales | 0.9x | 1.7x | Discount |
| EV / EBITDA | 9.5x | 15.9x | Discount |
| Return on equity | 9.0% | — | Weak |
| Gross margin | 18.1% | 17.4% | In line |
| Debt / Equity | 0.61 | 1.02 | Moderate |
| Piotroski / Altman Z | 8/9 | Z 2.69 | Grey zone |
Discounted cash flow model
Stock news · updated daily
HOUSTON, Oct. 1, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its third quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m.
Core Laboratories' 35.1% six-month slide contrasts with stronger Production Enhancement trends and offshore recovery potential amid geopolitical risks.
The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
Strict capital discipline by upstream energy companies is acting as a dampener, making the outlook for the Zacks Oil and Gas-Field Services industry gloomy. FTI, OII and CLB are expected to survive the industry woes.
BlackRock Inc. acquired a new stake in Core Laboratories Inc. (NYSE: CLB) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,460,118 shares of the oil and gas company's stock, valued at approximately $86,910,000. BlackRock Inc. owned 16.26% of Core Laboratories
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Advisors Capital Management LLC purchased a new stake in Core Laboratories Inc. (NYSE: CLB) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 237,398 shares of the oil and gas company's stock, valued at approximately $2,766,000. Advisors Capital Management LLC owned 0.52% of Core
On June 30, 2026, John Rogers (Trades, Portfolio), founder of Ariel Investment, LLC, increased the firm's stake in Core Laboratories Inc (NYSE: CLB) by 904,557 s
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | 0.09 | 0.11 | Beat 26.6% | $124.6M |
| Apr 29, 2026 | 0.06 | 0.06 | Beat 0.0% | $121.8M |
| Feb 4, 2026 | 0.19 | 0.21 | Beat 9.8% | $138.3M |
| Oct 22, 2025 | 0.19 | 0.22 | Beat 15.8% | $134.5M |
| Jul 23, 2025 | 0.18 | 0.19 | Beat 5.6% | $130.2M |
| Apr 23, 2025 | 0.15 | 0.14 | Miss -6.7% | $123.6M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 5, 2026 | 2026-10-05 12:18:10 | View |
| 4 | Oct 5, 2026 | 2026-10-05 12:17:23 | View |
| 8-K | Aug 25, 2026 | 2026-08-25 16:51:00 | View |
| SC 13G/A | Aug 14, 2026 | 2026-08-14 15:39:16 | View |
| SC 13G/A | Aug 14, 2026 | 2026-08-14 09:57:25 | View |
| SC 13G/A | Aug 6, 2026 | 2026-08-06 13:24:27 | View |
| 4 | Aug 4, 2026 | 2026-08-04 10:40:31 | View |
| 4 | Aug 4, 2026 | 2026-08-04 10:36:22 | View |
| 4 | Aug 4, 2026 | 2026-08-04 10:27:07 | View |
| 10-Q | Jul 30, 2026 | 2026-07-30 17:13:26 | View |
Proxy statement (DEF 14A) disclosures
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Tattoli Mark Damian | officer: SVP, Gen Counsel & Secretary | M-Exempt | 700 | — |
| Oct 1, 26 | Tattoli Mark Damian | officer: SVP, Gen Counsel & Secretary | F-InKind | 276 @ $9.76 | $2.69K |
| Oct 1, 26 | Tattoli Mark Damian | officer: SVP, Gen Counsel & Secretary | M-Exempt | 700 | — |
| Oct 1, 26 | Teo Sow Hang | officer: CAO & Treasurer | M-Exempt | 250 | — |
| Oct 1, 26 | Teo Sow Hang | officer: CAO & Treasurer | F-InKind | 99 @ $9.76 | $966 |
| Oct 1, 26 | Teo Sow Hang | officer: CAO & Treasurer | M-Exempt | 250 | — |
| Jul 31, 26 | Bruno Lawrence | director, officer: Chairman and CEO | P-Purchase | 5,000 @ $10.78 | $53.90K |
| Aug 1, 26 | Teo Sow Hang | officer: CAO & Treasurer | M-Exempt | 240 | — |